Peter Thiel was the first large investor in Facebook. Now he’s turning his investing skills to biotechnology.
Gene-editing companies say research on altering the DNA of human reproductive cells is dangerous and unethical.
A startup called Thync will sell electrodes that you put on your head to improve your mood. The results may vary to a surprising degree.
Scientists are developing ways to edit the DNA of tomorrow’s children. Should they stop before it’s too late?
Scientific advances and new business models are spurring investor confidence in biomedical-related ventures.
A global network of millions of genomes could be medicine’s next great advance.
Availability: 1-2 years
A new method for growing human brain cells could unlock the mysteries of dementia, mental illness, and other neurological disorders.
Fast DNA-sequencing machines are leading to simple blood tests for cancer.
A new mathematical model of the way the disease spreads in West Africa predicts that the Ebola epidemic should be over by the middle of the spring.
Stem-cell advocates pin their hopes on a method of treating diabetes.